Interestingly, recent trials have shown that tirzepatide is more effective than semaglutide
The studies show that when women with obesity lose weight with semaglutide, they improve their body composition with reduced waist circumference, indicative of less visceral fat, and they also reduce their risk of heart attacks and strokes while improving their quality of life, from migraine burden to depression and menopause symptoms
Without insurance, monthly cash-pay approaches list price, and a compounded pathway offers a separate published structure, including Tirzepatide Injection
The breaking point came when the old 3PL tried to raise their price
Nevertheless, the efficacy of LEAP2 monotherapy does not match that of GLP-1 receptor (GLP-1R) agonists, suggesting that combination therapies or further optimization may be required to realize their full therapeutic potential [221]